Pathogenesis Mechanism of Geminivirus-Encoded AL2
双生病毒编码的AL2的发病机制
基本信息
- 批准号:8223862
- 负责人:
- 金额:$ 21.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntiviral AgentsArabidopsisBindingBiologicalBiological ModelsChromatinComplexDNADNA VirusesDefectDefense MechanismsDiseaseEnvironmentEpigenetic ProcessEukaryotaEventFamilyFunctional disorderGeminiviridaeGene ExpressionGene SilencingGenesGoalsHealthHost DefenseHumanImmune responseImmune systemInfectionInvestigationKnowledgeLeadMeasuresMethylationModelingModificationMolecularNatural ImmunityPathogenesisPathway interactionsPharmaceutical PreparationsPlantsPlayPolycombPredispositionProcessProteinsRNA InterferenceResearchRoleSignal TransductionSingle Stranded DNA VirusSystemTestingViralVirusWorkbasechromatin modificationcombatdefense responsegain of function mutationheterochromatin-specific nonhistone chromosomal protein HP-1human diseaseinfancyinsightloss of functionnovelpathogenresearch studyvirus host interaction
项目摘要
DESCRIPTION (provided by applicant): The primary goal of the proposed research is to elucidate the mechanism of host innate immune responses and viral counter-defense responses at an epigenetic level. Multi-cellular eukaryotes including humans and plants have evolved sophisticated and fundamental mechanisms of RNA silencing to defense invasive viruses. On the other hand, viruses including those infecting humans encode proteins, referred to as viral suppressors, to block silencing pathways to evade host surveillance. The current world-wide study on host-virus interaction focuses on the antivirus role of posttranscriptional gene silencing (PTGS) and viral suppression of PTGS. While our knowledge of viral suppression at the PTGS level has been drastically expanded, our understanding of viral suppression at the level of transcriptional gene silencing (TGS) is still at its infancy. The preliminary studies from the PI's group have illuminated that AL2 suppressor encoded by geminivirus, a family of single-strand DNA viruses, genetically interferes with the pathway of Heterochromatin Protein 1 (HP1) and Polycomb Repressive Complex 2 (PRC2), which are critical genes responsible for epigenetic silencing. Moreover, AL2 biochemically interacts with HP1. These results and work from several other groups led to conceptualization of a model that TGS serves as an innate immune system to restrict invasive DNA pathogens, whereas viral suppressors can break this restriction by directly inhibiting the TGS integrators. The proposed study will address this model: Aim1 will test the hypothesis that HP1/PRC2 is a new line of host antivirus system and AL2 interaction with these components represents a novel counter-defense strategy. Effect of loss-of-function and gain-of-function mutations of HP1/PRC2 genes on modification of geminivirus chromatin will be investigated. Aim 2 will address a speculation that, through interaction with HP1/PRC2, AL2 can reprogram host gene expression and trigger downstream pathogenesis signaling cascades that disrupt host cellular environment leading to disease. A total of 30 AL2-responsive genes have been selected and whether nor not these genes are involved in AL2-elicited pathogenesis processes will be investigated. The proposed study will serve as the starting point for further comprehensive studies on the molecular mechanism of pathogenesis triggered by viral suppressors from the DNA viruses. Understanding these mechanisms will elucidate basic events that occur at the interface between virus and host, and will reveal natural antiviral defense strategies that may be exploited for directed therapies or preventative measures to address health disorders that arise from epigenetic dysfunction in mammalian hosts.
PUBLIC HEALTH RELEVANCE: Multi-cellular eukaryotes including humans and plants have evolved sophisticated and conserved epigenetic silencing mechanisms to protect themselves from virus attack. The proposed study is to elucidate the mechanisms by which geminivirus-encoded AL2 protein suppresses epigenetic silencing and triggers downstream pathogenesis signaling cascades that lead to diseases. The proposed study on Arabidopsis immune responses to infection by model DNA viruses and the viral counter- defensive strategies will provide mechanistic insights into the molecular interactions between viruses and mammalian hosts.
描述(由申请人提供):拟议研究的主要目标是在表观遗传水平上阐明宿主先天免疫应答和病毒反防御应答的机制。包括人类和植物在内的多细胞真核生物已经进化出复杂和基本的RNA沉默机制来防御入侵病毒。另一方面,包括感染人类的病毒在内的病毒编码称为病毒抑制子的蛋白质,以阻断沉默途径以逃避宿主监视。目前世界范围内对宿主-病毒相互作用的研究主要集中在转录后基因沉默(PTGS)的抗病毒作用和PTGS对病毒的抑制作用。虽然我们在PTGS水平上对病毒抑制的了解已经大大扩展,但我们对转录基因沉默(TGS)水平上的病毒抑制的理解仍处于起步阶段。PI小组的初步研究表明,由双生病毒(一种单链DNA病毒家族)编码的AL 2抑制基因在遗传上干扰异染色质蛋白1(HP 1)和多梳抑制复合物2(PRC 2)的途径,这两个基因是表观遗传沉默的关键基因。此外,AL 2与HP 1发生生物化学相互作用。这些结果和其他几个小组的工作导致了一个模型的概念化,即TGS作为先天免疫系统来限制侵入性DNA病原体,而病毒抑制剂可以通过直接抑制TGS整合剂来打破这种限制。拟议的研究将解决这一模型:Aim 1将测试假设,即HP 1/PRC 2是一种新的宿主抗病毒系统,AL 2与这些组件的相互作用代表了一种新的反防御策略。将研究HP 1/PRC 2基因的功能丧失和功能获得突变对双生病毒染色质修饰的影响。目的2将解决一种推测,即通过与HP 1/PRC 2的相互作用,AL 2可以重新编程宿主基因表达,并触发下游致病信号级联,破坏宿主细胞环境,导致疾病。总共选择了30个AL 2应答基因,将研究这些基因是否参与AL 2引起的发病过程。这项研究将作为进一步全面研究DNA病毒抑制子引发发病机制的分子机制的起点。了解这些机制将阐明在病毒和宿主之间的界面发生的基本事件,并将揭示天然的抗病毒防御策略,可用于定向治疗或预防措施,以解决哺乳动物宿主中表观遗传功能障碍引起的健康疾病。
公共卫生关系:包括人类和植物在内的多细胞真核生物已经进化出复杂和保守的表观遗传沉默机制来保护自己免受病毒攻击。该研究旨在阐明双生病毒编码的AL 2蛋白抑制表观遗传沉默并触发下游致病信号级联导致疾病的机制。拟对模式DNA病毒感染的拟南芥免疫反应和病毒的防御策略进行研究,将为深入了解病毒与哺乳动物宿主之间的分子相互作用机制提供理论依据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiuren Zhang其他文献
Xiuren Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiuren Zhang', 18)}}的其他基金
Roles of SWI/SNF complexes in posttranscriptional processing of RNA
SWI/SNF 复合物在 RNA 转录后加工中的作用
- 批准号:
10355465 - 财政年份:2019
- 资助金额:
$ 21.55万 - 项目类别:
Roles of SWI/SNF complexes in posttranscriptional processing of RNA
SWI/SNF 复合物在 RNA 转录后加工中的作用
- 批准号:
10191950 - 财政年份:2019
- 资助金额:
$ 21.55万 - 项目类别:
Roles of SWI/SNF complexes in posttranscriptional processing of RNA
SWI/SNF 复合物在 RNA 转录后加工中的作用
- 批准号:
9905546 - 财政年份:2019
- 资助金额:
$ 21.55万 - 项目类别:
Suppression mechanism of Geminivirus-encoded TrAP protein
双子病毒编码的TrAP蛋白的抑制机制
- 批准号:
10389066 - 财政年份:2018
- 资助金额:
$ 21.55万 - 项目类别:
Suppression mechanism of Geminivirus-encoded TrAP protein
双生病毒编码的TrAP蛋白的抑制机制
- 批准号:
10294234 - 财政年份:2018
- 资助金额:
$ 21.55万 - 项目类别:
Suppression mechanism of Geminivirus-encoded TrAP protein
双子病毒编码的TrAP蛋白的抑制机制
- 批准号:
10059255 - 财政年份:2018
- 资助金额:
$ 21.55万 - 项目类别:
Pathogenesis Mechanism of Geminivirus-Encoded AL2
双生病毒编码的AL2的发病机制
- 批准号:
8416325 - 财政年份:2012
- 资助金额:
$ 21.55万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 21.55万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 21.55万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 21.55万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 21.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 21.55万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 21.55万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 21.55万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 21.55万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 21.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 21.55万 - 项目类别: